🇺🇸 FDA
Patent

US 10279010

Methods and compositions for modulating myofibroblast activities

granted A61KA61K38/17A61K38/1709

Quick answer

US patent 10279010 (Methods and compositions for modulating myofibroblast activities) held by The Regents of the University of California expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/17, A61K38/1709, A61K38/1841, A61P